Met Life Investment Management, LLC Fate Therapeutics Inc Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 42,652 shares of FATE stock, worth $97,673. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,652
Previous 59,989 28.9%
Holding current value
$97,673
Previous $196,000 23.98%
% of portfolio
0.0%
Previous 0.0%

Shares

41 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$3.12 - $5.57 $54,091 - $96,567
-17,337 Reduced 28.9%
42,652 $149,000
Q2 2024

Aug 13, 2024
BUY
$3.26 - $7.08 $70,611 - $153,352
21,660 Added 56.51%
59,989 $196,000
Q1 2024

May 14, 2024
BUY
$3.54 - $8.35 $135,684 - $320,047
38,329 New
38,329 $281,000
Q2 2023

Apr 29, 2024
BUY
$4.76 - $6.59 $209,459 - $289,986
44,004 New
44,004 $209,000
Q1 2023

May 09, 2024
BUY
$4.24 - $11.12 $186,576 - $489,324
44,004 New
44,004 $251 Million
Q1 2022

May 10, 2024
BUY
$29.67 - $60.28 $1.31 Million - $2.65 Million
44,004 New
44,004 $1.71 Million
Q1 2022

Mar 22, 2023
BUY
$29.67 - $60.28 $463,979 - $942,658
15,638 Added 55.13%
44,004 $1.71 Million
Q1 2022

May 12, 2022
BUY
$29.67 - $60.28 $463,979 - $942,658
15,638 Added 55.13%
44,004 $1.71 Million
Q4 2021

Jun 21, 2023
SELL
$47.84 - $64.34 $748,121 - $1.01 Million
-15,638 Reduced 35.54%
28,366 $1.66 Million
Q3 2021

Jun 21, 2023
SELL
$59.27 - $95.73 $926,864 - $1.5 Million
-15,638 Reduced 35.54%
28,366 $1.68 Million
Q2 2021

Jun 21, 2023
SELL
$67.25 - $92.52 $1.05 Million - $1.45 Million
-15,638 Reduced 35.54%
28,366 $2.46 Million
Q1 2021

May 17, 2024
SELL
$72.16 - $117.4 $718,930 - $1.17 Million
-9,963 Reduced 25.99%
28,366 $2.34 Million
Q1 2021

Jun 26, 2023
SELL
$72.16 - $117.4 $1.13 Million - $1.84 Million
-15,638 Reduced 35.54%
28,366 $2.34 Billion
Q1 2021

Mar 22, 2023
SELL
$72.16 - $117.4 $15,153 - $24,654
-210 Reduced 0.73%
28,366 $2.34 Million
Q1 2021

May 14, 2021
SELL
$72.16 - $117.4 $15,153 - $24,654
-210 Reduced 0.73%
28,366 $2.34 Million
Q4 2020

May 24, 2024
SELL
$38.09 - $100.95 $64,105 - $169,898
-1,683 Reduced 5.56%
28,576 $2.6 Million
Q4 2020

Jun 22, 2023
SELL
$38.09 - $100.95 $587,652 - $1.56 Million
-15,428 Reduced 35.06%
28,576 $2.6 Million
Q4 2020

Mar 22, 2023
SELL
$38.09 - $100.95 $64,105 - $169,898
-1,683 Reduced 5.56%
28,576 $2.6 Million
Q4 2020

Feb 16, 2021
SELL
$38.09 - $100.95 $64,105 - $169,898
-1,683 Reduced 5.56%
28,576 $2.6 Million
Q3 2020

May 24, 2024
BUY
$30.41 - $40.5 $101,691 - $135,432
3,344 Added 12.42%
30,259 $1.21 Billion
Q3 2020

Jun 26, 2023
SELL
$30.41 - $40.5 $417,985 - $556,672
-13,745 Reduced 31.24%
30,259 $1.21 Million
Q3 2020

Mar 22, 2023
BUY
$30.41 - $40.5 $101,691 - $135,432
3,344 Added 12.42%
30,259 $1.21 Million
Q3 2020

Nov 13, 2020
BUY
$30.41 - $40.5 $101,691 - $135,432
3,344 Added 12.42%
30,259 $1.21 Million
Q2 2020

May 24, 2024
SELL
$20.21 - $35.23 $230,676 - $402,115
-11,414 Reduced 29.78%
26,915 $923 Million
Q2 2020

Jun 26, 2023
SELL
$20.21 - $35.23 $345,368 - $602,045
-17,089 Reduced 38.84%
26,915 $923,000
Q1 2020

Jul 12, 2023
SELL
$17.28 - $31.88 $295,297 - $544,797
-17,089 Reduced 38.84%
26,915 $597,000
Q4 2019

Jul 12, 2023
SELL
$13.39 - $20.73 $228,821 - $354,254
-17,089 Reduced 38.84%
26,915 $526,000
Q4 2019

Mar 22, 2023
BUY
$13.39 - $20.73 $48,940 - $75,768
3,655 Added 15.71%
26,915 $526,000
Q4 2019

Feb 14, 2020
BUY
$13.39 - $20.73 $48,940 - $75,768
3,655 Added 15.71%
26,915 $527,000
Q3 2019

Jul 12, 2023
SELL
$15.47 - $22.5 $320,909 - $466,740
-20,744 Reduced 47.14%
23,260 $361,000
Q3 2019

Mar 22, 2023
SELL
$15.47 - $22.5 $71,517 - $104,017
-4,623 Reduced 16.58%
23,260 $361,000
Q3 2019

Nov 14, 2019
SELL
$15.47 - $22.5 $71,517 - $104,017
-4,623 Reduced 16.58%
23,260 $361,000
Q2 2019

Jul 12, 2023
SELL
$15.61 - $20.44 $251,648 - $329,513
-16,121 Reduced 36.64%
27,883 $566,000
Q1 2019

Jul 13, 2023
SELL
$13.15 - $18.71 $211,991 - $301,623
-16,121 Reduced 36.64%
27,883 $489,000
Q4 2018

Jul 13, 2023
SELL
$11.48 - $16.98 $185,069 - $273,734
-16,121 Reduced 36.64%
27,883 $357,000
Q4 2018

Mar 22, 2023
SELL
$11.48 - $16.98 $91,093 - $134,736
-7,935 Reduced 22.15%
27,883 $357,000
Q4 2018

Feb 14, 2019
SELL
$11.48 - $16.98 $91,093 - $134,736
-7,935 Reduced 22.15%
27,883 $358,000
Q3 2018

Jul 13, 2023
SELL
$8.75 - $16.29 $183,102 - $340,884
-20,926 Reduced 47.55%
23,078 $375,000
Q3 2018

Mar 22, 2023
SELL
$8.75 - $16.29 $71,627 - $133,349
-8,186 Reduced 18.6%
35,818 $583,000
Q3 2018

Nov 14, 2018
BUY
$8.75 - $16.29 $111,475 - $207,534
12,740 Added 55.2%
35,818 $583,000
Q1 2018

May 15, 2018
BUY
$6.3 - $13.77 $145,391 - $317,784
23,078 New
23,078 $225,000

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $222M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email